Leveraging Neoadjuvant and Adjuvant Immunotherapy to Improve Outcomes in Early-Stage Cancers

Leveraging Neoadjuvant and Adjuvant Immunotherapy to Improve Outcomes in Early-Stage Cancers

Chair and Moderator, Jennifer Wargo, MD, MMSc, Patrick M. Forde, MD, Matthew D. Galsky, MD, and Ronan J. Kelly, MD, MBA, discuss Immuno-Oncology in this CME/MOC/NCPD/CPE activity titled “Leveraging Neoadjuvant and Adjuvant Immunotherapy to Break Through the Outcomes Plateau, Prevent Recurrences, and Improve Curability in Early-Stage Cancers.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/DVD865. CME/MOC/NCPD/CPE credit will be available until December 22, 2022.